6-(5-chloropyridin-3-yl)-N-[(5,6-dimethoxypyridin-2-yl)methyl]-3-(2-fluorophenyl)pyrazine-2-carboxamide | 1256921-55-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 6-(5-chloropyridin-3-yl)-N-[(5,6-dimethoxypyridin-2-yl)methyl]-3-(2-fluorophenyl)pyrazine-2-carboxamide
• CAS: 1256921-55-7
• 化学式: C₂₄H₁₉ClFN₅O₃
• 分子量: 479.898
• InChiKey: ZZQLEMICUJANSY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  99.1
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• [EN] PYRAZINE CARBOXAMIDE OREXIN RECEPTOR ANTAGONISTS<br/>[FR] PYRAZINE CARBOXAMIDE ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE
  申请人：MERCK SHARP & DOHME

  公开号：WO2010141275A1

  公开（公告）日：2010-12-09

  The present invention is directed to pyrazine carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

  本发明涉及吡嗪羧酰胺化合物，这些化合物是促进睡眠素受体的拮抗剂，可用于治疗或预防涉及促进睡眠素受体的神经学和精神疾病和疾病。该发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及促进睡眠素受体的疾病中的用途。
• Polyethylene composition and process for producing same
  申请人：TOSOH CORPORATION

  公开号：US20040214953A1

  公开（公告）日：2004-10-28

  A polyethylene composition prepared by polymerizing ethylene and an optional olefin with ≧3 carbon atoms in the presence of a macromonomer, is provided. The macromonomer is a vinyl-terminated ethylene polymer prepared by polymerizing ethylene and an optional olefin with ≧3 carbon atoms, and the macromonomer has (A) Mn≧5,000, and Mw/Mn=2-5. The polyethylene composition comprises (C) branched polyethylene prepared by copolymerizing ethylene, the macromonomer and an optional olefin with ≧3 carbon atoms, and the macromonomer. The polyethylene composition has (D) a density of 0.890-0.980 g/cm 3 , (E) Mw=30,000-10,000,000, (F) Mw/Mn=2-30, (G) a long chain branch frequency of 0.01-3 per 1,000 C atoms, and (H) a shrinking factor (g′ value) of 0.1-0.9 as measured by GPC/intrinsic-viscosity. The polyethylene composition can be finely divided particles having (P) a powder bulk density of 0.15-0.50 g/cm 3 .

  本发明提供了一种聚乙烯组合物，其是通过在存在大分子单体的情况下聚合乙烯和可选的具有≥3个碳原子的烯烃制备的。所述大分子单体是通过聚合乙烯和可选的具有≥3个碳原子的烯烃制备的，其具有(A) Mn≥5,000，且Mw/Mn=2-5的乙烯基端的聚合物。所述聚乙烯组合物包括(C)支化聚乙烯，其是通过共聚乙烯、大分子单体和可选的具有≥3个碳原子的烯烃制备的。所述聚乙烯组合物具有(D)密度为0.890-0.980 g/cm3，(E) Mw=30,000-10,000,000，(F) Mw/Mn=2-30，(G) 0.01-3个每1,000个C原子的长链支化频率，以及(H) 通过GPC/内禀粘度测量的收缩因子（g'值）为0.1-0.9。所述聚乙烯组合物可以是具有(P)粉末堆密度为0.15-0.50 g/cm3的细分散粒子。
• PYRAZINE CARBOXAMIDE OREXIN RECEPTOR ANTAGONISTS
  申请人：Mercer Swati P.

  公开号：US20120065205A1

  公开（公告）日：2012-03-15

  The present invention is directed to pyrazine carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

  本发明涉及对草酰吡嗪类化合物的研究，这些化合物是促进睡眠激素受体的拮抗剂，可用于治疗或预防神经系统和精神疾病，以及与促进睡眠激素受体有关的疾病。本发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在预防或治疗与促进睡眠激素受体有关的疾病方面的使用。
• ETHYLENE POLYMER, CATALYST FOR PRODUCTION OF ETHYLENE POLYMER, AND PROCESS FOR PRODUCTION OF ETHYLENE POLYMER
  申请人：Tosoh Corporation

  公开号：EP1964860B1

  公开（公告）日：2017-07-05
• ETHYLENE POLYMER, CATALYST FOR ETHYLENE POLYMER PRODUCTION, AND METHOD FOR PRODUCING ETHYLENE POLYMER
  申请人：Yamada Satoru

  公开号：US20090137755A1

  公开（公告）日：2009-05-28

  An object of the present invention relates to provide an ethylene polymer having excellent mechanical strength and excellent molding processability in a wide molding processing temperature range. The invention relates to use an ethylene polymer comprising a repeating unit derived from ethylene, or a repeating unit derived from ethylene and a repeating unit derived from a C 3-8 α-olefin, the ethylene polymer being satisfied with the following (A) to (F). (A) Density (d(kg/m 3 )) is from 910 to 970, (B) MFR(g/10 min)) is from 0.01 to 50, (C) terminal vinyl number is 0.2 or less per 1,000 carbon atoms, (D) melt strength (MS 160 (mN)) measured at 160° C. and MFR are satisfied with MS 160 >90−130×log(MFR), (E) melt strength (MS 190 (mN)) measured at 190° C. and MS 160 are satisfied with MS 160 /MS 190 <1.8, and (F) fluidized activation energy (E a (kJ/mol)) and d are satisfied with 127−0.107 d